Prenatal

Best-in-class: Basic Prenatal

Thorne Basic Prenatal. Per three capsules the filed panel declares vitamin A 1.05 mg (450 mcg as beta-carotene, 600 mcg as vitamin A palmitate), vitamin C 150 mg, vitamin D 25 mcg as D3, vitamin E 33.5 mg as d-alpha-tocopheryl, vitamin K 100 mcg as K1, thiamine 5 mg, riboflavin 5 mg as riboflavin 5'-phosphate sodium, niacin 30 mg as niacinamide, vitamin B6 12 mg as pyridoxal 5'-phosphate, folate 1.7 mg DFE as L-5-methyltetrahydrofolate, vitamin B12 200 mcg as methylcobalamin, biotin 50 mcg, pantothenic acid 18 mg, choline 110 mg, calcium 180 mg, iron 45 mg as Ferrochel, iodine 150 mcg, magnesium 90 mg, zinc 25 mg, selenium 50 mcg, copper 2 mg, manganese 5 mg, chromium 100 mcg and boron 1 mg.

How Prenatal actually works

The micronutrient package for conception and pregnancy: folate for neural tube closure in the first four weeks, iron for expanded plasma volume, iodine for fetal brain development, choline for the same, and DHA for third-trimester neural accretion. Requirements for several of these rise sharply and early — often before pregnancy is confirmed.

Where to get Prenatal

The evidence for Prenatal

Graded by what exists behind each claim.

✅ Clinically validated

• Adequate folate before/early pregnancy dramatically reduces neural-tube defects (one of the strongest nutrition findings).
• Prenatal micronutrients (iron, iodine, DHA-pairing) support healthy pregnancy outcomes.

📊 Correlative data

• Preconception micronutrient status is associated with pregnancy and infant outcomes.

🧪 Theoretical / extrapolated benefits

• Active folate is preferred for MTHFR carriers; broad superiority is reasonable and increasingly standard.

How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →

What Prenatal actually does

This page is written against the filed label rather than against prenatals in general. Thorne's Basic Prenatal, three capsules, as recorded with the NIH Dietary Supplement Label Database: 1 mg of L-5-methyltetrahydrofolate (1.7 mg DFE), 45 mg of iron as ferrous bisglycinate chelate, 150 mcg of iodine as potassium iodide, 25 mcg (1,000 IU) of vitamin D3, 200 mcg of methylcobalamin, 110 mg of choline as choline citrate, and 1.05 mg RAE of vitamin A split as 450 mcg beta-carotene plus 600 mcg retinyl palmitate NIH 2025. Four of those numbers carry real outcome arguments and one carries a hard ceiling. Take them in order.

Folate is two jobs, and only one of them is famous. 5-methyl-THF is the methyl donor for methionine synthase, which remethylates homocysteine to methionine using B12 as its cofactor; methionine becomes S-adenosylmethionine, the methyl donor for DNA and histones. Separately, the folate pool supplies one-carbon units to thymidylate synthase — dUMP to dTMP — and to purine synthesis. That second job is DNA replication, and the neural epithelium closing a neural tube between day 21 and day 28 after conception is one of the fastest-dividing tissues an embryo ever has. That is the whole biology of the folate argument: a proliferation demand at a moment most women do not yet know they are pregnant.

Folic acid and methylfolate are not the same molecule and the difference is an enzyme. Folic acid is pteroylglutamic acid, fully oxidized and synthetic; it does not exist in food. Before it can enter the cycle it must be reduced twice by dihydrofolate reductase. When human liver DHFR was actually measured, its activity was extremely low and varied almost five-fold between individuals Bailey 2009. That is the molecular reason unmetabolized folic acid turns up in plasma after ordinary supplemental doses: the reducing step is a bottleneck in humans in a way it is not in rats. L-5-MTHF is already past that step. It enters the cycle directly, and MTHFR — the enzyme whose common C677T variant produces a thermolabile, lower-activity protein Frosst 1995 — is also bypassed, because 5-MTHF is what MTHFR makes.

Iodine's mechanism is a transporter and a window. Iodide is concentrated into the thyroid by the sodium-iodide symporter, organified onto thyroglobulin tyrosines by thyroid peroxidase, and released as T4. The fetal thyroid does not begin producing meaningful hormone until around the end of the first trimester, so before that, every molecule of thyroid hormone in a fetal brain came from its mother, crossing the placenta as T4 and being deiodinated locally to T3 where it drives neuronal migration and cortical layering. Pregnancy also raises renal iodide clearance and thyroxine-binding globulin, so requirement rises exactly when the supply line matters most.

Iron's mechanism is a hormone you have probably never heard of. Non-heme iron is reduced at the duodenal brush border, imported by DMT1 and exported into blood by ferroportin — and ferroportin is degraded by hepcidin, the liver peptide that sets systemic iron absorption. Hepcidin falls as pregnancy progresses, which is the body opening the gate: red cell mass expands by roughly a quarter and the fetus and placenta take a few hundred milligrams outright. A prenatal iron dose is not treating a diet, it is meeting a physiological demand that has a switch behind it.

Vitamin A is the one that is dangerous in both directions, and the mechanism explains why. Retinol is oxidized to retinaldehyde and then irreversibly to retinoic acid, which binds RAR and RXR nuclear receptors and directly patterns the embryo — hindbrain segmentation, the outflow tract of the heart, the limb bud, the craniofacial skeleton. Retinoic acid is a morphogen: the instruction is carried by the concentration gradient, so too much corrupts the pattern exactly as too little does. Beta-carotene escapes the ceiling because the enzyme that cleaves it, BCO1, is feedback-regulated and simply stops converting when stores are full. That is why the label's split into 450 mcg carotene and 600 mcg preformed retinol NIH 2025 is a safety decision rather than a marketing one.

And choline is folate's backup route. Choline is oxidized to betaine, and betaine-homocysteine methyltransferase remethylates homocysteine without using folate at all. The two pathways cover for each other, which is why choline intake changes how much folate a person needs — and why 110 mg, a fifth of the daily value NIH 2025, is a gap rather than a solution.

Cell, rodent, human — and where it stops

The folate outcome data are the strongest result in nutritional obstetrics, and they belong to a different molecule than the one in this bottle. The MRC Vitamin Study randomized 1,817 women at high risk — women who had already had a neural-tube-defect pregnancy. Of 1,195 completed pregnancies there were 27 neural tube defects: 6 in the folic acid groups and 21 in the other groups, a 72% protective effect, relative risk 0.28 (95% CI 0.12 to 0.71) MRC Vitamin Study Research Group 1991. That is not a marginal finding and it changed public health policy worldwide.

Now the obstacle, stated with the numbers rather than hedged. MRC gave 4 mg of folic acid daily. This label carries 1 mg of L-5-MTHF NIH 2025 — a different molecule at a quarter of the mass. A 2024 evidence review of exactly this question concluded that there is a lack of clinical studies evaluating 5-MTHF supplementation for the prevention of neural tube defects, and that clinical studies are urgently needed to support its efficacy, dosage, timing and safety Samaniego-Vaesken 2024. The biochemical case for methylfolate is genuinely good: it bypasses a human enzyme that is slow and variable Bailey 2009, and in women homozygous for MTHFR 677TT it raised plasma folate more effectively than folic acid did. In that crossover, AUC and C_max were higher and t_max shorter for [6S]-5-MTHF in both genotypes, and unmetabolized folic acid appeared regularly in plasma after folic acid but rarely after methylfolate Prinz-Langenohl 2009 Frosst 1995. The outcome case is entirely folic acid's. Both sentences are true and neither should be dropped.

Iodine: an observational cohort with an uncomfortable effect size. In 1,040 first-trimester UK women, median urinary iodine was 91.1 µg/L (IQR 53.8–143) and the iodine-to-creatinine ratio 110 µg/g (IQR 74–170) — below the adequacy threshold for pregnancy. Children of the iodine-deficient mothers were more likely to sit in the lowest quartile for verbal IQ (odds ratio 1.58, 95% CI 1.09–2.30, p = 0.02), reading accuracy (1.69, 1.15–2.49, p = 0.007) and reading comprehension (1.54, 1.06–2.23, p = 0.02) Bath 2013. The obstacle here is the design: this is a cohort, not a trial, and no randomized trial of iodine supplementation in mild deficiency has ever used child cognition as its endpoint. It is also worth reading the label arithmetic: 150 mcg is 52% of the pregnancy and lactation daily value NIH 2025. The supplement is designed to close half a gap. The other half is dairy, fish and iodized salt, and a woman avoiding all three is not covered by this bottle.

Vitamin A: the ceiling has a study behind it and a number. Among 22,748 pregnant women, 339 of whom had babies with birth defects, the prevalence ratio for defects in cranial-neural-crest tissue was 3.5 (95% CI 1.7 to 7.3) in women consuming more than 15,000 IU of preformed vitamin A daily compared with 5,000 IU or less, and 4.8 (95% CI 2.2 to 10.5) when the high intake came from supplements — about 1 infant in 57 with a defect attributable to the exposure Rothman 1995. Do the arithmetic against the label: 600 mcg of preformed retinol is roughly 2,000 IU, which is a fifth of the 3,000 mcg RAE (10,000 IU) preformed ceiling used in pregnancy NIH 2025. The product is not the risk. What you add to it is.

DHA is the argument where the biggest trial came back empty. DOMInO randomized 2,399 women to 800 mg/day of DHA from before 21 weeks until birth. High depressive symptoms: 9.67% versus 11.19%, adjusted relative risk 0.85 (95% CI 0.70 to 1.02), P = .09. Child cognitive score at 18 months: adjusted mean difference 0.01 (95% CI −1.36 to 1.37), P = .99. Language score: −1.42 (−3.07 to 0.22), P = .09 — numerically in the wrong direction Makrides 2010. So the reason to take DHA in pregnancy is not maternal mood and not toddler IQ.

The reason it is taken is gestational length, and even there the literature disagrees with itself in a way worth seeing. A meta-analysis of 37 randomized trials found preterm birth down 11% (RR 0.89, 95% CI 0.82–0.97) and early preterm birth down 27% (RR 0.73, 0.58–0.92) — and then, after sensitivity analysis, neither survived (0.92, 0.83–1.01 and 0.82, 0.61–1.09), and its authors concluded that omega-3 does not reduce the risk Serra 2021. The ISSFAL consensus reading of the same field reaches a conditional conclusion instead, and the condition is the point: women low in omega-3 benefit most, adequate intake in early pregnancy is associated with lower risk, and where supplementation is used about 1,000 mg/day of DHA plus EPA started before 20 weeks is the effective regimen Best 2022. That is the site's recurring obstacle appearing in a consensus statement: this works on a deficit, and a woman who eats oily fish twice a week is not the woman it was measured in.

Prenatal — which form, and does it matter

The folate form, with the part of the name that matters. The label specifies L-5-methyltetrahydrofolate, 1 mg, declared as 1.7 mg DFE NIH 2025. The stereochemistry is the whole point: only the [6S] diastereomer is biologically usable, and a racemic [6R,S] mixture delivers half its mass as a molecule the body cannot put into the cycle. The trial evidence that methylfolate outperforms folic acid on plasma folate in MTHFR 677TT women used the [6S] form Prinz-Langenohl 2009. A label saying only “methylfolate” with no stereochemistry and no salt is not making the same claim.

The iron form is the compliance decision. 45 mg of elemental iron as ferrous bisglycinate chelate NIH 2025 against the 27 mg pregnancy daily value — 167%. Ferrous sulfate at that elemental dose is the classic cause of the nausea and constipation that make women stop taking prenatals in the first trimester, which is the trimester that matters. An amino-acid chelate keeps the iron coordinated through the stomach rather than releasing free ferrous ion into the gut lumen, and the practical read-out is a supplement that gets taken. A prenatal you cannot keep down has an efficacy of zero.

The iodine form is the one to check on a competitor's label. Potassium iodide NIH 2025 is a defined salt delivering a defined amount. Kelp and other seaweed-based prenatals deliver iodine at concentrations that vary by species, harvest site and season, and the same capsule count can supply a fraction of the label claim or a large multiple of it. In the one nutrient where both too little and too much cause thyroid trouble Bath 2013, an unpredictable source is the wrong design.

The vitamin A split is the safety-critical formulation choice. 450 mcg beta-carotene plus 600 mcg retinyl palmitate NIH 2025. A product that delivered the same 1.05 mg RAE entirely as retinyl palmitate would use up more than a third of the preformed ceiling Rothman 1995 for no additional benefit. This is the number to read on any prenatal, and it is usually printed in parentheses where nobody looks.

Two deliberate shortfalls, and one of them is good formulation. Calcium is 180 mg, 14% of the daily value, and choline 110 mg, 20% NIH 2025. The calcium is low on purpose: calcium and iron compete for absorption in the same duodenal window, so a full calcium dose in the same capsule would undercut the 45 mg of iron beside it. Choline is low because choline is bulky — the daily value is 550 mg and no three-capsule product can carry it — and this is the nutrient most prenatals quietly leave to eggs and meat.

And what is not in it at all: DHA NIH 2025. That is normal for a capsule prenatal, since a gram of fish oil will not fit beside the minerals, and it means the omega-3 argument above Best 2022 has to be met with a second product or with food.

What would have to be true, and how you would know it was not

1. folate-rbc, not serum folate, and the distinction is not pedantic. Serum folate reflects the last few days of intake and will rise on the first week of any folate product, telling you nothing. Red cell folate is incorporated as the erythrocyte is made and reports the preceding three to four months. Predict a rise that plateaus at about 16 weeks, and retest then rather than at four. In a woman carrying MTHFR 677TT Frosst 1995, predict the methylfolate product achieves that plateau at least as well as an equivalent folic acid dose would Prinz-Langenohl 2009.

2. ferritin, where falling is the expected result and not a failure. Plasma volume expands and the fetus draws iron, so ferritin declines through pregnancy on any regimen. The prediction is therefore comparative: on 45 mg/day NIH 2025 predict ferritin stays above about 30 µg/L into the third trimester, where an unsupplemented woman with a modest starting store would fall below it. Draw it at booking and once each trimester, alongside an iron-panel if the first result is low, and treat a ferritin under 30 as a finding rather than a fluctuation.

3. homocysteine, which is the cheapest functional read-out on the page. This label supplies methylfolate, methylcobalamin and pyridoxal-5-phosphate NIH 2025 — the three inputs to the remethylation and transsulfuration branches. Predict homocysteine falls within 8 to 12 weeks, and predict the largest fall in whoever started highest. A homocysteine that does not move on this combination is worth explaining rather than ignoring; B12 status and renal function are the usual explanations.

4. tsh and free-t4, with an honest statement of what they cannot tell you. Predict TSH stays inside the trimester-specific reference interval. But the iodine argument is about a fetal brain Bath 2013, and there is no maternal blood marker for that. Maternal TSH is a proxy for whether the mother's own thyroid is coping, not for whether the supply to the fetus was sufficient. Anyone who tells you a normal TSH proves your iodine intake was adequate is over-reading the test.

5. The prediction that cuts against the product, and it is not a small one. In a woman who was already replete — iron-sufficient, using iodized salt, eating eggs and oily fish — predict that none of the markers above moves meaningfully, and predict no outcome difference either. Every result on this page is a deficit being corrected: MRC enrolled women at high risk MRC Vitamin Study Research Group 1991, the iodine signal was in the deficient group Bath 2013, and the omega-3 consensus says explicitly that women low in omega-3 benefit most Best 2022. A prenatal in a replete woman is insurance against a diet going wrong, and that is a reasonable thing to buy; it is not the same purchase as treatment, and it should not be priced or believed as one.

6. And the prediction that matters more than any blood test. Predict that a prenatal started at the first positive pregnancy test delivers no neural tube benefit whatsoever. The tube closes by day 28 after conception; a test turns positive around day 14 after conception at the earliest and usually later; MRC's design was periconceptional, from before conception MRC Vitamin Study Research Group 1991. The single most important variable on this entire page is not the form of the folate, the dose of the iron or the brand on the bottle. It is the date you started.

What nobody has tested yet

Nobody has run a neural-tube-defect outcome trial of methylfolate, and the 2024 review says so in as many words. There is a lack of clinical studies evaluating 5-MTHF for NTD prevention and studies are urgently needed on efficacy, dosage, timing and safety Samaniego-Vaesken 2024. Worth adding what the review does not: such a trial may never be run. Neural tube defects occur in roughly one pregnancy in a thousand in fortified populations, so a trial powered for that endpoint against an active comparator would need tens of thousands of women, and no ethics committee would now randomize anyone to no folate. Methylfolate is therefore likely to be judged on red cell folate forever. Saying that out loud is more useful than implying the trial is coming.

Nobody has randomized iodine in mild deficiency with a child cognitive endpoint. ALSPAC is a cohort Bath 2013. The confounding is obvious — women with adequate iodine differ in diet, income and education from women without — and the effect sizes are large enough that the question deserves better than adjustment. The trial would take eight years to read out, which is why it has not been done.

Nobody knows the right choline dose in pregnancy. Choline and folate substitute for each other at the homocysteine remethylation step, so the folate requirement is choline-dependent and vice versa; this label carries a fifth of the daily value NIH 2025; and no prenatal formulation has been tested at a choline dose chosen on the basis of an outcome. It is the most under-studied ingredient in the category.

And nobody has tested this product. Every argument above is a single-nutrient argument. Multivitamins are almost never trialed as products, so “the prenatal works” is a sum of separate findings assembled by a formulator, not a result. That is not a reason to skip it — the components' evidence is real MRC Vitamin Study Research Group 1991 Bath 2013 — but it is the reason nobody can tell you this one is better than another, and anyone who does is selling.

Prenatal — its own safety story, not its category's

The iron and a toddler, with the arithmetic done. The label carries its own warning that accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six NIH 2025, and the number behind that sentence is worth seeing. Forty-five milligrams of elemental iron per three-capsule serving is 15 mg per capsule; a 30-serving bottle is 90 capsules and therefore about 1,350 mg of elemental iron. The threshold commonly used for symptomatic iron poisoning is around 20 mg per kilogram, so a 12 kg toddler reaches it at roughly 240 mg — sixteen capsules, well under a fifth of one bottle. Sweet-coated capsules, a handbag, a curious two-year-old. This is the most dangerous object discussed anywhere in this section of the site and it is dangerous to somebody other than the person who bought it.

The vitamin A ceiling belongs to everything you take, not to this bottle. 600 mcg of preformed retinol here NIH 2025 against a 3,000 mcg RAE preformed ceiling leaves roughly 2,400 mcg of headroom, and it is easy to spend: cod liver oil is a concentrated preformed-retinol product, a second multivitamin doubles the number, and one modest portion of beef or lamb liver carries several thousand micrograms in a single meal — more than the whole daily ceiling at once. The prevalence ratio for cranial-neural-crest defects at high supplemental intake was 4.8 Rothman 1995. Beta-carotene does not count against this and carrots are not the problem. Retinoids are a separate and absolute matter: oral isotretinoin and acitretin are among the most potent human teratogens known, and that is a pregnancy-prevention conversation with a dermatologist, not a supplement question.

The interaction almost nobody states, in a population where it is common. Iron and calcium both bind levothyroxine in the gut and reduce its absorption — and this label carries 45 mg of iron and 180 mg of calcium in the same three capsules NIH 2025. Hypothyroidism in pregnancy is managed to a tight TSH target with dose changes every few weeks, and a prenatal swallowed at the same time as the levothyroxine will quietly lower the level being titrated. Separate them by four hours — thyroid tablet on waking, prenatal with lunch or dinner — and tell whoever is adjusting the dose which you are doing.

Iodine cuts both ways and the danger is not this dose. 150 mcg of potassium iodide NIH 2025 is a physiological amount. Large iodine loads — kelp products, iodine tinctures, contrast media — can transiently shut down thyroid hormone synthesis, and in someone with autoimmune thyroid disease the shutdown may not be transient. Anyone with Hashimoto's or Graves' disease starting a new iodine source should be doing it with the person managing their thyroid, not instead of them.

Who should not take this one as sold. Anyone already prescribed a separate iron supplement, unless the total has been added up. Anyone with hereditary hemochromatosis. Anyone taking a second multivitamin or a cod liver oil, until the preformed vitamin A in both has been counted Rothman 1995. And anyone who has previously had a neural-tube-defect pregnancy should know that the trial in that population used 4 mg of folic acid daily MRC Vitamin Study Research Group 1991 — four times this label's folate mass, in a different molecule NIH 2025 — which makes it a prescription conversation before conception rather than a shelf decision.

Two reassurances, because a page that only frightens is not useful. Pyridoxal-5-phosphate at 12 mg NIH 2025 sits far below the 100 mg per day upper intake level; the sensory neuropathy that B6 is feared for belongs to hundreds of milligrams taken for months. And 200 mcg of methylcobalamin reads alarmingly as 7,142% of a daily value only because the daily value is tiny; B12 has no upper limit, absorption is capped by intrinsic factor, and the excess is excreted.

Sources read for this page

• NIH DSLD. Basic Prenatal (Thorne) — Supplement Facts, DSLD label ID 328830. NIH Dietary Supplement Label Database, label recorded 2025
• MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991 · PMID 1677062
• Samaniego-Vaesken ML, et al. Supplementation with Folic Acid or 5-Methyltetrahydrofolate and Prevention of Neural Tube Defects: An Evidence-Based Narrative Review. Nutrients 2024 · PMID 39339754
• Prinz-Langenohl R, et al. [6S]-5-methyltetrahydrofolate increases plasma folate more effectively than folic acid in women with the homozygous or wild-type 677C-->T polymorphism of methylenetetrahydrofolate reductase. British Journal of Pharmacology, 2009 · PMID 19917061
• Frosst P, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics, 1995 · PMID 7647779
• Bailey SW, et al. The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. Proceedings of the National Academy of Sciences 2009 · PMID 19706381
• Bath SC, et al. Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: results from the Avon Longitudinal Study of Parents and Children (ALSPAC). Lancet 2013 · PMID 23706508
• Rothman KJ, et al. Teratogenicity of high vitamin A intake. New England Journal of Medicine 1995 · PMID 7477116
• Makrides M, et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children. JAMA 2010 · PMID 20959577
• Best KP, Gibson RA, Makrides M. ISSFAL statement number 7 - Omega-3 fatty acids during pregnancy to reduce preterm birth. Prostaglandins, Leukotrienes and Essential Fatty Acids 2022 · PMID 36228573
• Serra R, Penailillo R, Monteiro LJ, et al. Supplementation of Omega 3 during Pregnancy and the Risk of Preterm Birth: A Systematic Review and Meta-Analysis. Nutrients 2021 · PMID 34069867

How you would know if it worked

Prenatal — safety & side effects

Bloodwork to run alongside Prenatal

Baseline first, then again at 8–12 weeks.

The Basics — Start Here panel covers these in one order — 4 markers, $32.40 with the discount applied.

Check results you already have → · All 103 markers A–Z

Prenatal — frequently asked questions

Prenatal inside a finished plan

One arm of 1 Protocol Blueprint, free to read in full.

What Prenatal is used for

Prenatal appears under 1 goal in the goal router.

Related Hormonal & Wellness supplements

← Browse the full Supplement Vault

↑ Back to on this page